Prevention Genetics Logo

Oncology tests

Germline genetic testing for cancer can identify potentially causative variants resulting in improved outcomes through faster diagnosis and informed treatment decisions. Explore our comprehensive test menu, created and curated by experts, for pediatric and adult tumors and hereditary cancer syndromes including Gorlin, Li-Fraumeni, Lynch, and hereditary breast and ovarian cancer syndrome (HBOC).

Showing 10 out of 34 tests

Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer Syndrome BRCA1/2 Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5451
2 Genes

Hereditary Central Nervous System/Brain Cancer Panel

NGS with CNV (PGselect platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 7969
26 Genes

Hereditary Colorectal Cancer and Polyposis Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5467
25 Genes

Hereditary Ovarian Cancer Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5469
30 Genes

Hereditary Paraganglioma and Pheochromocytoma Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 1329
12 Genes

Infantile Myofibromatosis Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 10091
2 Genes

Lynch Syndrome/Constitutional Mismatch Repair Deficiency Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5463
5 Genes

Lynch Syndrome via MLPA of PMS2

Multiplex Ligation-Dependent Probe Amplification Assay
clock-circle2 - 3 weeks (6 - 11 days STAT)•Test 6062
1 Gene

Melanoma Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5473
10 Genes

Multiple Endocrine Neoplasia Type 1 via the MEN1 Gene

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 7503
1 Gene